Kyriacos Zygourakis
Chemical and Biomolecular Engineering
Useful Links
Mathematical Models
COVID-19 Data
(The New York Times)
Links with COVID-19 Info
Science:
The Washington Post:
The New York Times:
COVID-19: The Early Days
Science
(July 31, 2020)
"From ‘brain fog’ to heart damage, COVID-19’s lingering problems alarm scientists,” by Jennifer Couzin-Frankel
The Atlantic (July 30, 2020)
"We Need to Talk About Ventilation,” by Zeynep Tufekci
How is it that six months into a respiratory pandemic, we are still doing so little to mitigate airborne transmission?
Nature
(July 23, 2020)
Governments are starting to change policies amid concerns that tiny droplets can carry SARS-CoV-2. And after months of denying the importance of this, the World Health Organization is reconsidering its stance.
UCSF Magazine (Summer 2020)
"We Thought It Was Just a Respiratory Virus. We were wrong.” By Ariel Bleicher and Katherine Conrad
Refereed Articles
"It is Time to Address Airborne Transmission of COVID-19,” L. Morawska and D. K. Milton, Clinical Infectious Diseases. Published online July 6, 2020. doi:10.1093/cid/ciaa939
"We appeal to the medical community and to the relevant national and international bodies to recognize the potential for airborne spread of COVID-19. There is significant potential for inhalation exposure to viruses in microscopic respiratory droplets (microdroplets) at short to medium distances (up to several meters, or room scale), and we are advocating for the use of preventive measures to mitigate this route of airborne transmission.”
"Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review,”
W. J. Wiersinga et al, JAMA. Published online July 10, 2020.doi:10.1001/jama.2020.12839
"SARS-CoV-2 is spread primarily via respiratory droplets during close face-to-face contact. Infection can be spread by asymptomatic, presymptomatic, and symptomatic carriers... Approximately 5% of patients with COVID-19, and 20% of those hospitalized, experience severe symptoms necessitating intensive care. More than 75% of patients hospitalized with COVID-19 require supplemental oxygen… The case-fatality rate for COVID-19 varies markedly by age, ranging from 0.3 deaths per 1000 cases among patients aged 5 to 17 years to 304.9 deaths per 1000 cases among patients aged 85 years or older in the US. Among patients hospitalized in the intensive care unit, the case fatality is up to 40% "